Location: Home
  • search
  • go
  • Relate News
  • 11/27/2024NMPA Accepts Akeso's sNDA for Penpulimab Plus Anlotinib for Advanced H...
  • 11/27/2024CMS's CMS-D005 Gets Green Light for Its Obesity Drug Trials in China
  • 11/27/2024Policy Change Set to Advance Cell and Gene Therapy in China
  • 11/27/2024NHSA: Policies in Development to Synchronize Medical Insurance Funds a...
  • 11/27/2024China Introduces New Policy to Strengthen Hierarchical Medical Care an...
  • 11/27/2024Asian Market Rattled by Trump Tariffs: Yang Report (LinkedIn)
  • 11/26/2024Rise In Clinical Trial Activity Will Support Hong Kong, China’s Pharm...
  • 11/26/2024Snapshot of BMI System Financial Performance in 3Qs/2024
  • 11/25/2024Kanglin Biotech Announces $20M Series A Financing to Advance Gene Ther...
  • 11/25/2024Hanx Biopharma Submits IPO Application to HKSE
  • 11/25/2024Zhongsheng Announces Promising Phase II Results for Weight Loss Drug R...
  • 11/25/2024Junshi Secures Licensing Deal for Bispecific Fusion Proteins
  • 11/25/2024TG ImmunoPharma Completes Series Pre-A+ Financing to Accelerate Immuno...
  • 11/25/2024BRL Medicine Secures ~CNY 200M in Series B+ Financing to Advance Gene ...
  • 11/25/2024Rui Thera Present Clinical Trial Results of CD19 CAR NK Cell Therapy i...
  • 11/25/2024DP Tech and Lepu Biopharma Enter ADC Partnership
  • 11/25/2024China's Real-World Data Pilot Drives Global Collaboration and Regulato...
  • 11/22/2024Hua Medicine to Terminate China Commercialization Agreement with Bayer...
  • 11/22/2024NHC Issues the Opinions on Reforming and Improving the Grassroots Drug...
  • 11/22/2024Recent Executive Moves
  • 11/22/2024Cancer Incidence and Mortality in China, 2022 (JNCC)
  • 11/21/202469 New Drugs Granted Breakthru Therapy Designations in China This Year...
  • 11/21/2024CStone and Pharmalink Enter into Strategic Partnership for Sugemalimab...
  • 11/21/2024Pfizer and Zai Lab Announce Strategic Deal on Antibacterial Drug XACDU...
  • 11/21/2024Merck's Belzutifan Approved in China for VHL Disease-Associated Tumors
  • 11/21/2024RDPAC Reinforces Strategic Commitment to China's Pharmaceutical Market
  • 11/21/2024China Strengthens Focus on Gene and Cell Therapy Research in Suzhou
  • 11/21/2024Sino Biopharma Strengthens Oncology Portfolio with Investment in LaNov...
  • 11/20/2024FDA Issues Warning to Tianjin Darentang for Manufacturing and Transpar...
  • 11/20/2024J&J and Merck Restructure Operations in China Amid Market Challenges
  • Page:39/776 Total number of articles:23279: [First][<<] [37] [38] [39] [40] [41] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group